Medicare is a difficult market to be in and is going to get even more challenging in the next few years, experts say.
Medicare is a difficult market to be in and is going to get even more challenging in the next few years, experts say.
"Plans that want to succeed in the long term need to elevate their game," says John Gorman, CEO of Gorman Health Group, a Washington, D.C.-based Medicare managed care-consulting firm.
Some challenges include:
2023 Drug Trend Report - Xevant
May 16th 2024To effectively navigate the changing pharmacy landscape and maintain a robust, cost-effective pharmacy benefit, you must understand the forces behind rising drug trend. What’s driving your costs and what can you do about it? As a leader in the PBM analytics space, we offer a unique perspective on pivotal trend drivers. Here’s what our comprehensive analysis revealed: -A surge in utilization rates across specialty and non-specialty drugs, magnified by anti-obesity therapies -Financial strain imposed by anti-inflammatory biologics and the yet-to-be-fulfilled -promise of biosimilar savings -Persistent price inflation driving higher costs year over year
Read More